Bantam Pharmaceutical has deep experience in oncology drug discovery and development including R&D and partnering.
Bantam Pharmaceutical has raised $25.0M in total funding. The most recent round was Seed. The last funding was announced in September 2021.
Bantam Pharmaceutical's investors include Lionel Goldfrank.
Bantam Pharmaceutical is headquartered in Boston, United States.
Bantam Pharmaceutical has deep experience in oncology drug discovery and development including R&D and partnering.
Bantam Pharmaceutical is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Bantam Pharmaceutical — Funding & Investors." VCBacked, September 16, 2021, https://www.vcbacked.co/company/bantam-pharmaceutical. Accessed August 14, 2026.
VCBacked. (2021). Bantam Pharmaceutical — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/bantam-pharmaceutical
{{cite web |title=Bantam Pharmaceutical — Funding & Investors |url=https://www.vcbacked.co/company/bantam-pharmaceutical |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated